Rohto Pharmaceutical Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Rohto Pharmaceutical Co., Ltd.

Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社, 4527), Pharmaceutical. 25 cross-shareholdings, a board of 19 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YE5N, filed 2026-06-19. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-31199.621.1274.992.6136.006,866
2023-03-31238.726.4309.7115.6232.007,176
2024-03-31270.830.9346.2135.6127.007,259
2025-03-31308.630.8437.0135.3836.009,144
2026-03-31343.734.2485.8151.5646.009,292

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
Mitsubishi UFJ Financial Group, Inc.1,380,0003.60.0
OHKI HEALTHCARE HOLDINGS CO.,LTD.1,759,5302.312.9
MatsukiyoCocokara&Co.665,7001.70.2
WAKAMOTO PHARMACEUTICAL CO.,LTD.3,971,9001.411.4
Sumitomo Mitsui Financial Group, Inc.213,3001.10.0
MORISHITA JINTAN CO., LTD.355,0000.88.7
Meiji Holdings Co.,Ltd.180,4000.70.1
Senshu Ikeda Holdings, Inc.810,6700.70.3
The Nanto Bank,Ltd.376,0000.5—
YOMEISHU SEIZO CO., LTD.126,5000.50.9

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown